期刊文献+
共找到37,839篇文章
< 1 2 250 >
每页显示 20 50 100
Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation:Effects on virus replication and recurrent hepatitis 被引量:236
1
作者 Philip Hilgard Alisan Kahraman +7 位作者 Nils Lehmann Cornelia Seltmann Susanne Beckebaum R Stefan Ross Hideo A Baba Massimo Malago Christoph E Broelsch Guido Gerken 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第5期697-702,共6页
AIM: To determine the effects of the calcineurin inhibitors, cyclosporine and tacrolimus, on hepatitis C virus (HCV) replication and activity of recurrent hepatitis C in patients post liver transplantation. METHODS... AIM: To determine the effects of the calcineurin inhibitors, cyclosporine and tacrolimus, on hepatitis C virus (HCV) replication and activity of recurrent hepatitis C in patients post liver transplantation. METHODS: The data of a cohort of 107 patients who received liver transplantation for HCV-associated liver cirrhosis between 1999 and 2003 in our center were retrospectively analyzed. The level of serum HCV-RNA and the activity of recurrent hepatitis were compared between 47 patients who received either cyclosporine or tacrolimus as the primary immunosuppressive agent and an otherwise similar immunosuppressive regimen which did not lead to biliary complications within the first 12 mo after transplantation. RESULTS: HCV-RNA increased within 3 mo after transplantation but the differences between the cyclosporine group and the tacrolimus group were insignificant (P=0.49 at 12 too). In addition, recurrent hepatitis as determined by serum transarninases and histological grading of portal inflammation and fibrosis showed no significant difference after 12 mo (P= 0.34).CONCLUSION: Cyclosporine or tacrolimus as a primary immunosuppressive agent does not influence the induction or severity of recurrent hepatitis in HCV- infected patients after liver transplantation. 展开更多
关键词 CYCLOSPORINE TACROLIMUS Liver transplantation recurrent hepatitis HCV-RNA
下载PDF
免疫型复发性流产的发病机制及诊断和治疗 被引量:77
2
作者 林其德 邱丽华 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第11期1275-1278,共4页
复发性流产(RSA)是临床上难以处理的不育症,发病率占妊娠总数的1%~5%。在从20世纪80年代末开始的针对RSA免疫发病机制与临床诊治的系统性研究过程中,发现RSA的发生与患者系统免疫和局部免疫异常有关,其中自身免疫型RSA主要与抗磷脂抗体... 复发性流产(RSA)是临床上难以处理的不育症,发病率占妊娠总数的1%~5%。在从20世纪80年代末开始的针对RSA免疫发病机制与临床诊治的系统性研究过程中,发现RSA的发生与患者系统免疫和局部免疫异常有关,其中自身免疫型RSA主要与抗磷脂抗体(APA)阳性有关,而同种免疫型RSA则与母胎免疫耐受失衡有关。建立了系统的免疫型RSA病因筛查流程和诊断体系,其中在国际上首创的ACL+β2-GP1双指标联合多次检测技术为免疫型RSA的分型诊断提供了有效手段;结合孕前和孕期临床多指标动态监测,在国际上首创小剂量、短疗程、个体化的免疫抑制和淋巴细胞主动免疫治疗,并对接受免疫治疗患者的子代进行随访,验证了该疗法的安全性和有效性。该项研究成果解决了长期以来困扰临床医师的RSA病因诊断难、治疗难等问题,极大地提高了我国RSA的诊治水平。 展开更多
关键词 流产 复发性 自身免疫型 同种免疫型 发病机制 诊断 免疫治疗
下载PDF
腰椎间盘突出症术后复发的临床分析 被引量:60
3
作者 郭钧 陈仲强 +1 位作者 齐强 郭昭庆 《中国脊柱脊髓杂志》 CAS CSCD 2004年第6期334-337,共4页
目的:探讨腰椎间盘突出症术后同节段复发的原因、诊断方法及影响二次手术疗效的因素。方法:32例有完整随访资料的椎间盘突出症术后复发病例,按治疗方式分为保守治疗组,椎板加椎间盘切除组与椎板、椎间盘切除加腰椎内固定植骨融合组。对... 目的:探讨腰椎间盘突出症术后同节段复发的原因、诊断方法及影响二次手术疗效的因素。方法:32例有完整随访资料的椎间盘突出症术后复发病例,按治疗方式分为保守治疗组,椎板加椎间盘切除组与椎板、椎间盘切除加腰椎内固定植骨融合组。对各种治疗方法的适应证、疗效等进行总结,分析椎间盘切除术后可能的复发原因。结果:本组病例均获5个月以上随访,保守治疗组优良率100%,腰椎融合组优良率92.9%,非融合组优良率93.2%。结论:腰椎间盘突出症术后同节段复发的确切原因仍不清楚,对诊断明确并伴有神经根损伤表现的患者可行二次手术治疗,是否采用内固定加植骨融合术视患者不同情况而定。 展开更多
关键词 腰椎间盘突出症 复发 原因 治疗
下载PDF
复发性缺血性脑卒中的危险因素、严重程度及短期预后分析 被引量:65
4
作者 田婷 关智媛 +2 位作者 石正洪 栗静 冯斌 《中国康复理论与实践》 CSCD 北大核心 2016年第2期172-177,共6页
目的探讨复发性缺血性脑卒中的危险因素,评价其严重程度及短期预后。方法 2014年3月~2015年3月,本院复发性缺血性脑卒中患者238例(复发组),性别和年龄匹配的初发缺血性脑卒中患者378例(初发组)。比较两组患者的临床资料并进行非条件Logi... 目的探讨复发性缺血性脑卒中的危险因素,评价其严重程度及短期预后。方法 2014年3月~2015年3月,本院复发性缺血性脑卒中患者238例(复发组),性别和年龄匹配的初发缺血性脑卒中患者378例(初发组)。比较两组患者的临床资料并进行非条件Logistic回归分析;对比两组患者入院和出院时美国国立卫生研究院卒中量表(NIHSS)评分及神经功能好转率。结果复发组脑白质疏松(χ~2=8.666)、高血压(χ~2=8.189)、吸烟(χ~2=6.973)、饮酒(χ~2=4.722)的发生率高于初发组(P<0.05)。Logistic回归分析显示,脑白质疏松(OR=1.690,95%CI:1.198~2.384,P=0.003)、高血压(OR=1.715,95%CI:1.135~2.592,P=0.010)、吸烟(OR=1.896,95%CI:1.233~2.915,P=0.004)是复发性缺血性脑卒中的独立危险因素。复发组入院及出院NIHSS评分均显著高于初发组(t=-3.645,t=-4.675,P<0.001),神经功能好转率明显低于初发组(t=2.643,P<0.01)。结论高血压、脑白质疏松、吸烟是复发性缺血性脑卒中的独立危险因素,复发性缺血性脑卒中患者较初发者病情严重,短期神经功能恢复慢。 展开更多
关键词 缺血性脑卒中 复发 危险因素 美国国立卫生研究院卒中量表 预后
下载PDF
经尿道精囊镜诊治顽固性或复发性血精162例临床资料分析 被引量:58
5
作者 王磊 刘智勇 +7 位作者 许传亮 孙颖浩 万蓬 盛夏 肖亮 朴曙光 叶华茂 鲁欣 《中华男科学杂志》 CAS CSCD 2013年第6期531-534,共4页
目的:分析经尿道精囊镜诊治顽固性或复发性血精的可行性和有效性。方法:回顾分析2007年1月至2010年7月采用经尿道精囊镜诊治的顽固性或复发性血精患者162例,患者年龄19~76岁,血精病史3个月至11年,术前均因血精就诊,均行血清PSA、经直... 目的:分析经尿道精囊镜诊治顽固性或复发性血精的可行性和有效性。方法:回顾分析2007年1月至2010年7月采用经尿道精囊镜诊治的顽固性或复发性血精患者162例,患者年龄19~76岁,血精病史3个月至11年,术前均因血精就诊,均行血清PSA、经直肠前列腺、精囊腔内B超以及盆腔CT或MRI检查,常规抗生素治疗4周效果欠佳或反复发作者,收治入院,行经尿道精囊镜检查。结果:全部病例术中均可见一侧或双侧精囊中暗红色或紫红色胶浆样物质和炎性改变,所有患者均取小块组织活检,病理结果回报为精囊黏膜慢性炎性改变,15例患者另可见射精管或精囊中结石;术后平均随访时间为21.7个月(12~29个月),92.6%(150/162)的患者在术后随访中经过1~15次射精后,血精消失或减轻。1例(67岁)患者因无射精活动而无法判断,7例患者术后血精消失超过3个月后复发,4例患者术后血精症状无减轻。1例患者术后发生急性双侧附睾炎,所有病例术后未见逆行射精、尿失禁或直肠损伤等并发症。结论:经尿道精囊镜技术是可行的诊断和治疗顽固性或复发性血精的新方法。 展开更多
关键词 血精 顽固性 复发性 精囊镜 经直肠超声
下载PDF
复发性腹股沟疝的临床特点和腹腔镜手术方式选择 被引量:49
6
作者 王文瑞 李健文 +5 位作者 王骥 乐飞 冯波 王明亮 陆爱国 郑民华 《中华消化外科杂志》 CAS CSCD 北大核心 2015年第10期827-831,共5页
目的:总结复发性腹股沟疝的临床特点,探讨其腹腔镜手术方式选择。方法:回顾性分析2001年1月至2014年12月上海交通大学医学院附属瑞金医院收治的330例(352侧)行腹腔镜腹股沟疝修补术复发性腹股沟疝患者的临床资料。手术由同组医师... 目的:总结复发性腹股沟疝的临床特点,探讨其腹腔镜手术方式选择。方法:回顾性分析2001年1月至2014年12月上海交通大学医学院附属瑞金医院收治的330例(352侧)行腹腔镜腹股沟疝修补术复发性腹股沟疝患者的临床资料。手术由同组医师完成,手术方式由术者选择行经腹腹膜前修补术(TAPP)、全腹膜外修补术(TEP)或腹腔内补片平铺术(IPOM)。观察指标包括前次手术的复发部位,此次手术的修补方法、手术方式选择和临床疗效。采用电话或门诊方式进行随访,随访内容为疝复发情况和术后并发症发生情况。随访时间截至2015年6月。正态分布的计量资料以±s表示,偏态分布的计量资料以M(范围)表示;计数资料比较采用χ2检验。结果:(1)复发部位:352侧复发疝中,直疝区域186侧,斜疝区域111侧,股疝区域6侧,复合疝区域49侧。125侧缝合修补术后复发疝中,直疝区域44侧,斜疝区域48侧,股疝区域2侧,复合疝区域31侧;110侧网塞平片修补术后复发疝中,直疝区域85侧,斜疝区域16侧,复合疝区域9侧;61侧平片修补术后复发疝中,直疝区域37侧,斜疝区域16侧,股疝区域3侧,复合疝区域5侧;36侧腹膜前修补术后复发疝中,直疝区域19侧,斜疝区域12侧,股疝区域1侧,复合疝区域4侧;14侧疝囊高位结扎术后复发疝中,直疝区域1侧,斜疝区域13侧;6侧硬化剂注射后复发疝均为斜疝。复发疝中直疝的比例为52.84%(186/352),高于初发疝的23.70%(998/4 211),两者比较,差异有统计学意义(χ^2=171.397,P〈0.05);植入补片的复发疝中直疝的比例为68.12%(141/207),高于未植入补片复发疝的31.03%(45/145),两者比较,差异有统计学意义(χ^2=47.052,P〈0.05)。(2)修补方法:未植入补片的复发疝和平片修补术后复发疝,均采用修补肌耻骨孔的方� 展开更多
关键词 腹股沟疝 复发性 治疗 腹腔镜检查
原文传递
125例复发/持续性分化型甲状腺癌再次手术及其预后影响因素分析 被引量:49
7
作者 张立阳 刘春浩 +3 位作者 曹越 刘洪沨 高维生 李小毅 《中国癌症杂志》 CAS CSCD 北大核心 2019年第6期412-417,共6页
背景与目的:分化型甲状腺癌虽然预后良好,但仍有一部分患者存在复发和(或)转移风险。通过总结再次手术的125例复发/持续性分化型甲状腺的临床资料,探讨其复发/持续原因及部位、再次手术风险及其预后的影响因素。方法:回顾性分析中国医... 背景与目的:分化型甲状腺癌虽然预后良好,但仍有一部分患者存在复发和(或)转移风险。通过总结再次手术的125例复发/持续性分化型甲状腺的临床资料,探讨其复发/持续原因及部位、再次手术风险及其预后的影响因素。方法:回顾性分析中国医学科学院北京协和医学院北京协和医院2008—2017年同一组医生收治的行手术治疗的复发/持续性性分化型甲状腺癌患者的病历资料。采用2015年美国甲状腺协会动态危险度评估系统对术后随访患者的治疗反应进行评估分级。结果:患者共125例,其中男性26例,女性99例;平均年龄42岁。再次手术原因包括残余腺体复发/持续45例(45/125,36.0%),中央组淋巴结复发/持续56例(56/125,44.8%),侧方淋巴结复发/持续58例(58/125,46.4%)。再次手术后并发症包括新发的永久性甲状旁腺功能减退者3例(3/125,2.4%),喉返神经麻痹者4例(4/125,3.2%)。患者术后平均随访61个月,5年完全缓解率为69.6%(87/125)。多因素分析结果显示,既往手术次数是影响患者预后的独立危险因素(OR=2.948,95%CI:1.125~7.725,P=0.028)。结论:残余腺体及局部淋巴结复发/持续是分化型甲状腺癌持续/复发的主要原因。再次手术风险较高,但有经验的甲状腺专科医生可以将风险控制在较低水平。分化型甲状腺癌复发/持续后再次手术治疗预后良好,既往手术次数是影响患者预后的独立危险因素。 展开更多
关键词 分化型甲状腺癌 持续 复发 动态危险度评估系统
下载PDF
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review 被引量:47
8
作者 Nicola de'Angelis Filippo Landi +1 位作者 Maria Clotilde Carra Daniel Azoulay 《World Journal of Gastroenterology》 SCIE CAS 2015年第39期11185-11198,共14页
AIM: To investigate the efficacy(survival) and safety of treatments for recurrent hepatocellular carcinoma(HCC) in liver transplantation(LT) patients.METHODS: Literature search was performed on available online databa... AIM: To investigate the efficacy(survival) and safety of treatments for recurrent hepatocellular carcinoma(HCC) in liver transplantation(LT) patients.METHODS: Literature search was performed on available online databases without a time limit until January 2015. Clinical studies describing survival after HCC recurrence in LT patients were retrieved for a fulltext evaluation. A total of 61 studies were selected: 13 case reports, 41 retrospective case series, and 7 retrospective comparative studies.RESULTS: Based on all included studies, the mean HCC recurrence rate was 16% of all LTs for HCC. A total of 1021 LT patients experienced HCC recurrence. The median time from LT to HCC recurrence was 13 mo(range 2-132 mo). The majority of patients(67%) presented with HCC extra-hepatic recurrences, involving lung, bone, adrenal gland, peritoneal lymph nodes, and rarely the brain. Overall survival after HCC recurrence was 12.97 mo. Surgical resection of localized HCC recurrence and Sorafenib for controlling systemic spread of HCC recurrence were associated with the higher survival rates(42 and 18 mo, res-pectively). However, Sorafenib, especially when combined with m TOR, was frequently associated with severe side effects that required dose reduction or discontinuation CONCLUSION: Management of recurrent HCC in LT patients is challenging and associated with poor prognosis independently of the type of treatment. 展开更多
关键词 recurrent HEPATOCELLULAR CARCINOMA LIVER transplan
下载PDF
Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: A systematic review 被引量:44
9
作者 George Sgourakis Ines Gockel Hauke Lang 《World Journal of Gastroenterology》 SCIE CAS 2013年第9期1424-1437,共14页
AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane... AIM: To investigate potential therapeutic recommendations for endoscopic and surgical resection of T1a/ T1b esophageal neoplasms. METHODS: A thorough search of electronic databases MEDLINE, Embase, Pubmed and Cochrane Library, from 1997 up to January 2011 was performed. An analysis was carried out, pooling the effects of outcomes of 4241 patients enrolled in 80 retrospective studies. For comparisons across studies, each reporting on only one endoscopic method, we used a random effects meta-regression of the log-odds of the outcome of treatment in each study. "Neural networks" as a data mining technique was employed in order to establish a prediction model of lymph node status in superficial submucosal esophageal carcinoma. Another data mining technique, the "feature selection and root cause analysis", was used to identify the most impor-tant predictors of local recurrence and metachronous cancer development in endoscopically resected patients, and lymph node positivity in squamous carcinoma (SCC) and adenocarcinoma (ADC) separately in surgically resected patients. RESULTS: Endoscopically resected patients: Low grade dysplasia was observed in 4% of patients, high grade dysplasia in 14.6%, carcinoma in situ in 19%, mucosal cancer in 54%, and submucosal cancer in 16% of patients. There were no significant differences between endoscopic mucosal resection and endoscopic submucosal dissection (ESD) for the following parameters: complications, patients submitted to surgery, positive margins, lymph node positivity, local recurrence and metachronous cancer. With regard to piecemeal resection, ESD performed better since the number of cases was significantly less [coefficient: -7.709438, 95%CI: (-11.03803, -4.380844), P < 0.001]; hence local recurrence rates were significantly lower [coefficient: -4.033528, 95%CI: (-6.151498, -1.915559),P < 0.01]. A higher rate of esophageal stenosis was observed following ESD [coefficient: 7.322266, 95%CI: (3.810146, 10.83439), P < 0.001]. A significantly greater number of SCC patients wer 展开更多
关键词 SUPERFICIAL ESOPHAGEAL cancer ENDOSCOPIC resection Mucosal infiltration SUBMUCOSAL involvement recurrent tumor Controversies in treatment Squamous cell carcinoma Adenocarcinoma Lymphatic invasion Vascular invasion SUBMUCOSAL LAYER SUPERFICIAL SUBMUCOSAL LAYER Middle third SUBMUCOSAL LAYER Deep third SUBMUCOSAL LAYER ESOPHAGEAL cancer ENDOSCOPIC GASTROINTESTINAL surgical procedures ENDOSCOPIC GASTROINTESTINAL surgery Lymph node dissection Dysplasia
下载PDF
左乙拉西坦联合丙戊酸钠或地西泮预防小儿热性惊厥反复发作的临床观察 被引量:43
10
作者 李学超 王建忠 +3 位作者 张冬艳 王淼 张芳 高宇 《中国药房》 CAS 北大核心 2016年第29期4106-4109,共4页
目的:探讨左乙拉西坦联合丙戊酸钠或地西泮治疗小儿热性惊厥(FS)反复发作的预防作用及安全性。方法:将90例FS反复发作患儿按随机数字表法分为观察组和对照组,各45例。对照组患儿给予丙戊酸钠或地西泮口服;观察组患儿在对照组治疗基... 目的:探讨左乙拉西坦联合丙戊酸钠或地西泮治疗小儿热性惊厥(FS)反复发作的预防作用及安全性。方法:将90例FS反复发作患儿按随机数字表法分为观察组和对照组,各45例。对照组患儿给予丙戊酸钠或地西泮口服;观察组患儿在对照组治疗基础上给予左乙拉西坦片口服,初始剂量为15 mg/kg,bid,连续用药7 d后逐渐减量,第8~12天减量至10 mg/kg,bid,第13~15天减量至5 mg/kg,bid,第16天停药。两组患儿均随访1年,每2个月进行1次常规检查。记录随访期间两组患儿发热次数、惊厥复发率和癫痫转化情况及不良反应发生率;分别于治疗前和治疗6个月后检测两组患儿血清神经元特异性烯醇化酶(NSE)和S-100β蛋白(S-100β)水平;并采用《中国修订韦氏儿童智力量表》和《儿童适应行为评定量表》分别对两组患儿的智商和行为能力进行测评。结果:观察组和对照组分别有3、2例患儿失访。随访期内,观察组患儿的发热次数和惊厥复发率均显著少于或低于对照组,差异有统计学意义(P〈0.05);两组患儿的癫痫转化率和不良发应发生率比较,差异均无统计学意义(P〉0.05)。治疗后,两组患儿的血清NSE和S-100β水平均较治疗前显著降低,且观察组患儿显著低于对照组,差异均有统计学意义(P〈0.05)。至末次随访,观察组患儿的言语智商、操作智商及总智商得分均显著高于对照组,认知因子、社会自制因子及行为能力总分均显著高于对照组,差异均有统计学意义(P〈0.05)。结论:左乙拉西坦联合丙戊酸钠或地西泮能够预防FS反复发作,减轻脑损伤,有助于改善患儿的智商和行为能力,从而提高其生活质量。 展开更多
关键词 左乙拉西坦 小儿 热性惊厥 反复发作 智商 行为能力
下载PDF
Minimal Gated Unit for Recurrent Neural Networks 被引量:38
11
作者 Guo-Bing Zhou Jianxin Wu +1 位作者 Chen-Lin Zhang Zhi-Hua Zhou 《International Journal of Automation and computing》 EI CSCD 2016年第3期226-234,共9页
Recurrent neural networks (RNN) have been very successful in handling sequence data. However, understanding RNN and finding the best practices for RNN learning is a difficult task, partly because there are many comp... Recurrent neural networks (RNN) have been very successful in handling sequence data. However, understanding RNN and finding the best practices for RNN learning is a difficult task, partly because there are many competing and complex hidden units, such as the long short-term memory (LSTM) and the gated recurrent unit (GRU). We propose a gated unit for RNN, named as minimal gated unit (MCU), since it only contains one gate, which is a minimal design among all gated hidden units. The design of MCU benefits from evaluation results on LSTM and GRU in the literature. Experiments on various sequence data show that MCU has comparable accuracy with GRU, but has a simpler structure, fewer parameters, and faster training. Hence, MGU is suitable in RNN's applications. Its simple architecture also means that it is easier to evaluate and tune, and in principle it is easier to study MGU's properties theoretically and empirically. 展开更多
关键词 recurrent neural network minimal gated unit (MGU) gated unit gate recurrent unit (GRU) long short-term memory(LSTM) deep learning.
原文传递
Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus 被引量:41
12
作者 Tianfu Wen Chen Jin +31 位作者 Antonio Facciorusso Matteo Donadon Ho-Seong Han Yilei Mao Chaoliu Dai Shuqun Cheng Bixiang Zhang Baogang Peng Shunda Du Changjun Jia Feng Xu Jie Shi Juxian Sun Peng Zhu Satoshi Nara JMichael Millis Qiu Li Weixia Chen Wusheng Lu Hong Tang Lvnan Yan Yong Zeng Bo Li Jiayin Yang Wentao Wang Hong Wu Mingqing Xu Zheyu Chen Changli Lu Chuan Li Wei Peng Xiaoyun Zhang 《Hepatobiliary Surgery and Nutrition》 SCIE 2018年第5期353-371,共19页
Hepatocellular carcinoma (HCC) is the sixth-most common cancer and the third leading cause of cancer-related death in the world. However, 40–70% patients eventually suffer from postoperative recurrence within 5 years... Hepatocellular carcinoma (HCC) is the sixth-most common cancer and the third leading cause of cancer-related death in the world. However, 40–70% patients eventually suffer from postoperative recurrence within 5 years. HCC recurrence after surgery severely affects prognosis of the patients. Nevertheless, there is an opportunity to improve patients' prognosis if doctors and researchers can recognize the importance of a standardized perioperative management and study it in clinical and pre-clinical settings. Hence, based on our own experience and published studies from other researchers, we develop this consensus regarding multidisciplinary management of locally recurrent and metastatic hepatocellular carcinoma after resection. This consensus consists of the entire course of recurrent hepatocellular carcinoma (RHCC) management, including prediction of recurrence, prevention, diagnosis, treatment and surveillance of RHCC. Consensus recommendations are presented with grades of evidences (Ia, Ib, IIa, IIb, III and IV), and strength ofrecommendations (A, B, C, D and E). We also develop a decision-making path for RHCC treatment, which can intuitively demonstrate the management for RHCC. It is hoped that we may make some effort to standardize the management of RHCC and ultimately understand how to improve outcomes. 展开更多
关键词 recurrent HEPATOCELLULAR carcinoma (RHCC) MULTIDISCIPLINARY management CONSENSUS
原文传递
复发性腰椎间盘突出症再手术的术式选择及疗效分析 被引量:39
13
作者 车艳军 陈亮 +3 位作者 杨惠林 顾勇 张志明 唐天驷 《中国脊柱脊髓杂志》 CAS CSCD 北大核心 2010年第9期730-735,共6页
目的:探讨三种术式治疗复发性腰椎间盘突出症的疗效分析。方法:对我院2004年4月~2009年10月收治的随访资料完整的78例腰椎间盘突出症术后复发再次手术患者进行回顾性研究。按照再次术前患者情况及手术方法分三组:A组27例,术前无腰椎失... 目的:探讨三种术式治疗复发性腰椎间盘突出症的疗效分析。方法:对我院2004年4月~2009年10月收治的随访资料完整的78例腰椎间盘突出症术后复发再次手术患者进行回顾性研究。按照再次术前患者情况及手术方法分三组:A组27例,术前无腰椎失稳、退变性滑脱或椎管狭窄,再次行椎间盘摘除术;B组15例,术前合并腰椎失稳、退变性滑脱或椎管狭窄,行椎间盘摘除+后外侧融合术(posterolateral fusion,PLF);C组36例,术前合并腰椎失稳,退变性滑脱或椎管狭窄,行椎间盘摘除+后路腰椎椎体间融合术(posterior lumbar interbody fusion,PLIF),B组、C组患者依据术前具体病情,术中均采用椎弓根螺钉内固定术。采用日本骨科学会(JOA)29分评分系统和腰痛及腿痛视觉疼痛评分(VAS)两项指标对患者术前、术后和末次随访时的神经功能及自觉症状进行评价,计算改善率,并对结果进行统计学分析。结果:78例患者再次术后均获得随访,随访时间6~36个月,平均24个月。JOA评分术前A组为9.96±2.59,B组为10.20±2.37,C组为9.14±3.16;术后2个月A组为20.37±5.21,B组为22.60±6.62,C组为21.45±6.09;末次随访A组为19.85±6.45,B组为20.40±6.47,C组为20.92±5.51。各组JOA评分与术前相比有统计学意义(P<0.05)。各组术前、术后及末次随访腰腿痛(VAS)评分,经配对t检验,差异有显著性(P<0.05);结论:腰椎间盘突出症术后复发根据不同病情采用不同的手术方式治疗,可以取得满意的临床效果。 展开更多
关键词 腰椎间盘突出症 复发 再手术 疗效
下载PDF
FH 17 cells in human recurrent pregnancy loss and ~re-eclampsia 被引量:38
14
作者 Binqing Fu 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2014年第6期564-570,共7页
T helper 17 (TH 17) cells have been identified as a new lineage of helper T cells and have been shown to be important in host defense against extracellular infectious agents, autoimmune disease and chronic inflammat... T helper 17 (TH 17) cells have been identified as a new lineage of helper T cells and have been shown to be important in host defense against extracellular infectious agents, autoimmune disease and chronic inflammatory diseases. Recently, TH17 cells have also been shown to participate in successful pregnancy, as well as in the pathogenesis of diseases of pregnancy, such as recurrent spontaneous abortion (RSA) and pre-eclampsia (PE). Here, we review our current knowledge of TH 17 cells in human RSA and PE. We also discuss how the local uterine microenvironment affects the differentiation of TH17 cells and the mechanisms that regulate TH17 cells during pregnancy. Research into TH17 cells will not only advance our understanding of TH 17-related pregnancy complications, but will also facilitate the design of novel therapies for reproductive diseases. 展开更多
关键词 TH17 cells human pregnancy recurrent spontaneous abortion PRE-ECLAMPSIA
原文传递
修正性鼻内镜手术治疗复发性鼻-鼻窦炎的临床分析 被引量:38
15
作者 杨驱云 赵侃 +2 位作者 沈毅 沈志森 俞杰 《中国内镜杂志》 北大核心 2015年第11期1198-1202,共5页
目的探讨慢性鼻-鼻窦炎鼻内镜术后复发的原因及提高修正性鼻内镜手术效果的相关措施。方法回顾性分析84例复发性鼻-鼻窦炎患者的临床资料,所有患者均在鼻内镜下行修正性手术,并在围手术期进行规范化的综合处理,术后随访12个月以上,观察... 目的探讨慢性鼻-鼻窦炎鼻内镜术后复发的原因及提高修正性鼻内镜手术效果的相关措施。方法回顾性分析84例复发性鼻-鼻窦炎患者的临床资料,所有患者均在鼻内镜下行修正性手术,并在围手术期进行规范化的综合处理,术后随访12个月以上,观察临床疗效。结果 84例患者术后1年,病情完全控制57例(67.9%),部分控制19例(22.6%),总有效率90.5%,未控制8例(9.5%)。术后无严重并发症。其中,伴有哮喘组有效率为79.2%,而无哮喘组的有效率为95.0%,经χ2检验差异有统计学意义(P<0.05)。结论慢性鼻-鼻窦炎鼻内镜术后复发原因主要有:病变窦腔开放不全、解剖变异未矫正、术腔增生粘连、骨炎和变应性炎症等。通过修正性鼻内镜手术,结合围手术期规范的综合治疗,复发性鼻-鼻窦炎治疗效果满意,合理的鼻内镜手术操作是提高复发性鼻-鼻窦炎疗效的关键。 展开更多
关键词 鼻内镜手术 复发 鼻-鼻窦炎 鼻息肉
下载PDF
Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis 被引量:35
16
作者 Bong-WanKim Hee-JungWang +1 位作者 Wook-HwanKim Myung-WookKim 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第3期431-436,共6页
AIM: To evaluate the efficacy of hilar duct oriented hepatectomy for intractable hepatolithiasis, the ventral hilum exposure (VHE) method that has been applied by the authors. METHODS: From June 1994 to June 2004 ... AIM: To evaluate the efficacy of hilar duct oriented hepatectomy for intractable hepatolithiasis, the ventral hilum exposure (VHE) method that has been applied by the authors. METHODS: From June 1994 to June 2004 for a period of 10 years, 153 patients who had Tsunoda type Ⅲ or Ⅳ hepatolithiasis, received hepatectomy at our institution. Among these patients, 128 who underwent hepatectomy by the VHE method were the subjects for the study. We analyzed the risk of this procedure, residual rate of intrahepatic stones, and stone recurrent rates. RESULTS: The average age was 54.2 years, and the male to female ratio was 1:1.7. The average follow-up period was 25.6 mo (6-114 too). There was no postoperative severe complication or mortality after the operation. The rate of residual stones was 5.4% and the rate of recurrent stones was 4.2%. CONCLUSION: VHE is a safe surgical procedure and provides favorable treatment results of intractable hepatolithiasis. Especially, this procedure has advantage in that intra-hepatic bile duct stricture may be confirmed and corrected directly during surgery. 展开更多
关键词 HEPATOLITHIASIS Hepatic resection Residual stone recurrent stone
下载PDF
复发性腰椎间盘突出症的再手术治疗 被引量:33
17
作者 申勇 杨大龙 +3 位作者 张英泽 丁文元 董玉昌 杜浩 《中国脊柱脊髓杂志》 CAS CSCD 2006年第4期255-258,共4页
目的:探讨椎管彻底减压、后路cage椎间融合、椎弓根系统内固定治疗复发性腰椎间盘突出症的效果。方法:对31例采用上述方法治疗的复发性腰椎间盘突出症患者进行回顾性分析,根据术前及术后随访时JOA评分(15分法)、术后患者主观满意度分级... 目的:探讨椎管彻底减压、后路cage椎间融合、椎弓根系统内固定治疗复发性腰椎间盘突出症的效果。方法:对31例采用上述方法治疗的复发性腰椎间盘突出症患者进行回顾性分析,根据术前及术后随访时JOA评分(15分法)、术后患者主观满意度分级及影像学结果评价手术效果,并分析其并发症。结果:31例平均手术时间150±2.3min,平均出血量620±5.6ml。平均随访40个月,手术前后JOA评分有显著差异(P<0.05),JOA评分临床改善率为84.09%,患者主观满意度优良率为87.10%,骨性融合率为97.18%。并发症包括6例硬膜撕破,1例一过性单侧神经根麻痹,1例假关节形成。结论:椎管彻底减压、后路cage椎间融合、椎弓根系统内固定治疗复发性腰椎间盘突出症效果满意,无严重并发症发生。 展开更多
关键词 后路椎间融合 腰椎间盘突出症 复发 椎间融合器 再手术
下载PDF
食管癌放疗后复发的再放疗32例疗效观察 被引量:34
18
作者 贾丽 王仁本 +4 位作者 于金明 孟繁会 郭英华 李金丽 朱昆莉 《中华肿瘤防治杂志》 CAS 2006年第11期863-864,共2页
观察根治性放疗后局部复发食管癌患者适形超分割放疗的疗效,分析2000年5月~2005年3月我院收治的32例放疗后局部复发采用适形超分割放疗患者临床及随访资料。CR 19例(59.4%),PR 7例(21.9%),SD 3例(9.3%),PD 3例(9.3... 观察根治性放疗后局部复发食管癌患者适形超分割放疗的疗效,分析2000年5月~2005年3月我院收治的32例放疗后局部复发采用适形超分割放疗患者临床及随访资料。CR 19例(59.4%),PR 7例(21.9%),SD 3例(9.3%),PD 3例(9.3%)。6个月、1年、2年和3年生存率分别为65.6%(21/32)、53.3%(16/30)、28、6%(8/28)和14.3%(3/21)。死亡原因:局部失败16例,全身广泛转移8例,食管气管瘘5例。初步研究结果提示,三维适形超分割放疗可作为食管癌根治性放疗后局部复发患者的一种有效治疗手段。 展开更多
关键词 食管肿瘤/放射疗法 复发 生存率
下载PDF
Paleoearthquake rupture behavior and recurrence of great earthquakes along the Haiyuan fault, northwestern China 被引量:32
19
作者 ZHANG Peizhen MIN Wei DENG Qidong MAO Fengying 《Science China Earth Sciences》 SCIE EI CAS 2005年第3期364-375,共12页
The Haiyuan fault is a major seismogenic fault in north-central China where the 1920 Haiyuan earthquake of magnitude 8.5 occurred, resulting in more than 220000 deaths. The fault zone can be divided into three segment... The Haiyuan fault is a major seismogenic fault in north-central China where the 1920 Haiyuan earthquake of magnitude 8.5 occurred, resulting in more than 220000 deaths. The fault zone can be divided into three segments based on their geometric patterns and associated geomorphology. To study paleoseismology and recurrent history of devastating earthquakes along the fault, we dug 17 trenches along different segments of the fault zone. Although only 10 of them allow the paleoearthquake event to be dated, together with the 8 trenches dug previously they still provide adequate information that enables us to capture major paleoearthquakes oc- curring along the fault during the past geological time. We discovered 3 events along the eastern segment during the past 14000 a, 7 events along the middle segment during the past 9000 a, and 6 events along the western segment during the past 10000 a. These events clearly depict two temporal clusters. The first cluster occurs from 4600 to 6400 a, and the second occurs from 1000 to 2800 a, approximately. Each cluster lasts about 2000 a. Time period between these two clus- ters is also about 2000 a. Based on fault geometry, segmentation pattern, and paleoearthquake events along the Haiyuan fault we can identify three scales of earthquake rupture: rupture of one segment, cascade rupture of two segments, and cascade rupture of entire fault (three segments). Interactions of slip patches on the surface of the fault may cause rupture on one patch or ruptures of more than two to three patchs to form the complex patterns of cascade rupture events. 展开更多
关键词 PALEOEARTHQUAKE event recurrent interval earthquake RUPTURE pattern temporal clustering SLIP patch interaction.
原文传递
微血管减压术与经皮穿刺球囊压迫治疗复发三叉神经痛的疗效比较 被引量:33
20
作者 胡强 俞文华 +6 位作者 杜权 朱强 车志豪 王昊 董晓巧 杨定博 沈永锋 《临床神经外科杂志》 CAS 2018年第1期26-30,33,共6页
目的探讨微血管减压术(MVD)与经皮穿刺球囊压迫(PBC)治疗MVD术后复发三叉神经痛的临床疗效。方法回顾性分析2009年1月至2016年1月分别采用MVD(25例,MVD组)与PBC(67例,PBC组)治疗的MVD术后复发三叉神经痛患者的临床资料,比较两组患者的... 目的探讨微血管减压术(MVD)与经皮穿刺球囊压迫(PBC)治疗MVD术后复发三叉神经痛的临床疗效。方法回顾性分析2009年1月至2016年1月分别采用MVD(25例,MVD组)与PBC(67例,PBC组)治疗的MVD术后复发三叉神经痛患者的临床资料,比较两组患者的手术疗效、手术时间、住院时间及并发症。结果 MVD组和PBC组的有效率分别为96.0%和94.0%,两组比较差异无统计学意义(P>0.05);MVD组治愈率高于PBC组(88.0%vs 64.2%,P<0.05);PBC组复发率高于MVD组(27.0%vs4.2%,P<0.05);MVD组手术时间及住院时间长于PBC组[(102.0±28.2)min vs(20.9±10.6)min,(11.7±3.5)d vs(4.3±1.8)d,均P<0.05);PBC组三叉神经抑制反应、面部麻木发生率高于MVD组(26.9%vs4.0%,92.5%vs 16.0%,均P<0.05);MVD组与PBC组口角疱疹发生率比较差异无统计学意义(32.0%vs40.3%,P>0.05)。PBC组出现咀嚼肌乏力37例;MVD组发生切口感染1例,术侧耳鸣1例。结论 MVD和PBC均能有效治疗MVD术后复发三叉神经痛。MVD的治愈率高,复发率低,三叉神经抑制反应、面部麻木、咀嚼肌乏力等并发症少;而PBC具有安全性高、创伤小、手术时间及住院时间短的优点。 展开更多
关键词 三叉神经痛 微血管减压术 球囊压迫 复发
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部